Equities research analysts at StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS - Get Free Report) in a research note issued to investors on Tuesday. The firm set a "hold" rating on the stock.
Separately, Benchmark restated a "speculative buy" rating and issued a $1.25 price objective on shares of Milestone Scientific in a report on Wednesday, November 20th.
Check Out Our Latest Analysis on MLSS
Milestone Scientific Price Performance
NYSE:MLSS traded up $0.21 during mid-day trading on Tuesday, reaching $1.00. The company's stock had a trading volume of 960,617 shares, compared to its average volume of 112,881. The company's fifty day simple moving average is $0.83 and its two-hundred day simple moving average is $0.84. Milestone Scientific has a twelve month low of $0.52 and a twelve month high of $1.10. The stock has a market cap of $77.89 million, a P/E ratio of -12.93 and a beta of 1.08.
Insider Transactions at Milestone Scientific
In related news, Director Leonard Osser sold 107,984 shares of the firm's stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total transaction of $100,425.12. Following the sale, the director now directly owns 4,606,882 shares in the company, valued at approximately $4,284,400.26. This trade represents a 2.29 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Insiders have sold a total of 109,193 shares of company stock worth $101,634 in the last three months. 24.75% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On Milestone Scientific
Several hedge funds have recently modified their holdings of the stock. Y Intercept Hong Kong Ltd purchased a new stake in Milestone Scientific during the 3rd quarter worth approximately $48,000. World Investment Advisors LLC purchased a new stake in Milestone Scientific during the 3rd quarter worth approximately $91,000. Finally, Geode Capital Management LLC grew its position in shares of Milestone Scientific by 6.4% in the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company's stock worth $480,000 after acquiring an additional 31,572 shares in the last quarter. 5.79% of the stock is currently owned by hedge funds and other institutional investors.
About Milestone Scientific
(
Get Free Report)
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Recommended Stories
Before you consider Milestone Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Milestone Scientific wasn't on the list.
While Milestone Scientific currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
